 |
 |
 |
Study
Designs
First-in-Human
Pharmacokinetics (Phase I)
Pharmacodynamics (Phase II)
Drug-Drug Interaction
Methods Development
Limited Phase III |
|
|
 |
 |
 |
School
of Medicine Collaborations
Infectious Disease
Pulmonary
Rheumatology
Endocrinology
Dermatology
Gynecology & Obstetrics
Neurology
Ophthalmology
Pathology
Psychiatry
Pediatrics
Surgery |
|
|
 |

|
 |
Sponsors
30 Industry Sponsors
National Institutes of Health
Centers for Disease Control
Food and Drug Administration
Department of Defense
US Agency for International Development |
|
|
 |
 |
 |
Special
Populations
Healthy Volunteers
HIV, HCV, TB
Intensive Care
Pregnancy
Lactating Women
Pediatrics
Healthy Gerontology
Dermatologic disease
Rheumatologic Disease
Hepatic impairment |
|
|